Autopsy report · NCT01125449

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Cause of deathDrug or device supply, also regulatory or ethics Automatic label, confidence 0.6, unverified. How labels are made.

“Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche (Ireland).”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Situs Cancer Research Center
Sponsor type: University, hospital or other
Conditions: Sarcoma; Adenocarcinoma; Carcinoma; Multiple Myeloma; Desmoplastic Small Round Cell Tumor
Interventions: Ascorbic acid (vitamin C)
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.